Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Gamida Cell to Report Second Quarter 2023 Financial Results

Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that the company will release its financial results for the second quarter ended June 30, 2023 on Monday, August 14, 2023.

Following the release, management will host a conference call and live webcast at 8:30 am Eastern Time to discuss the financial results, provide corporate updates and answer questions.

To access the conference call by phone, please register here and be advised to do so at least 10 minutes prior to joining. A live webcast of the conference call can be accessed by computer in the "Investors & Media" section of the Gamida Cell website at www.gamida-cell.com. A replay of the webcast will be available approximately two hours after the event, for approximately 30 days.

About Gamida Cell

Gamida Cell is a cell therapy pioneer working to turn cells into powerful therapeutics. The company's proprietary nicotinamide (NAM) technology leverages the properties of NAM to enhance and expand cells, creating allogeneic cell therapy products and candidates that are potentially curative for patients with hematologic malignancies. These include Omisirge®, an FDA-approved nicotinamide modified allogeneic hematopoietic progenitor cell therapy, and GDA-201, an NK cell therapy candidate being investigated for the treatment of hematologic malignancies. For additional information, please visit www.gamida-cell.com or follow Gamida Cell on LinkedIn, Twitter, Facebook or Instagram.

These press releases may also interest you

at 04:09	CGTN: China, Kazakhstan cherish friendly ties, vow further cooperation
	China and Kazakhstan have always supported each other and have always been partners in times of challenges, Chinese President Xi Jinping said in a signed article in the Kazakhstanskaya Pravda newspaper and Kazinform International News Agency on...
at 04:05	H.I.G. Capital Signs Definitive Agreement to Acquire CGH Group
	H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $64 billion of capital under management, is pleased to announce that an affiliate has signed a definitive agreement to acquire CGH Group S.A. ("CGH" or the "Company"), a...
at 03:55	INC Unveils Gen Z Preferences for Nuts and Dried Fruits and Snacking in Latin America
	The International Nut and Dried Fruit Council (INC), conducted an extensive study on Latin America's Gen Z dietary...
at 03:44	Invitation to presentation of the interim report January-June 2024 for Truecaller AB (publ)
	Truecaller, the leading global platform for verifying contacts and blocking unwanted communication, is publishing its interim report for January-June on Friday 19 July 2024 at 07.30 CET. Alan Mamedi, CEO and Odd Bolin, CFO presents the report and...
at 03:20	Launch of Phase 3 clinical trial with Nefecon in Japan
	Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...
at 03:09	CGTN: China, Kazakhstan cherish friendly ties, vow further cooperation
	China and Kazakhstan have always supported each other and have always been partners in times of challenges, Chinese President Xi Jinping said in a signed article in the Kazakhstanskaya Pravda newspaper and Kazinform International News Agency on...
	More news about Science and technology...

News published on 1 august 2023 at 08:10 and distributed by:

Gamida Cell to Report Second Quarter 2023 Financial Results

These press releases may also interest you

Le Lézard

Others sections

Follow us